Cerebricon - Press Releases

Cerebricon Ltd. Obtains 3rd Party Transgenic SOD1 License for the Study of ALS
26 Nov 2007 16:23

Cerebricon Ltd. and Pronexus Analytical AB Sign Exclusive Agreement in the Areas of Marketing and Scientific Collaboration
26 Nov 2007 15:46

Cerebricon Ltd. and Neurological Models Inc. Announce Strategic Alliance.
12 Sep 2007 14:47

Cerebricon Ltd. and Neuromolecular Models Inc. (Danvers, MA) Announce Strategic Alliance
30 Aug 2007 14:50

Cerebricon to Exhibit at the 2007 Society for Neuroscience (SFN) Annual Meeting in San Diego
09 Aug 2007 11:05

Cerebricon Increases Focus on Translational Aspects of Preclinical Drug Development: Imaging/MRI/MRS
03 Aug 2007 10:45

Cerebricon Increases Focus on Imaging Technology
02 Aug 2007 11:45

Cerebricon Announces Updates To Product Portfolio
01 May 2007 12:14

Cerebricon to Exhibit at the BIO-Europe Spring 2007 in Milan, Italy.
26 Jan 2007 11:10

Cerebricon Appoints New Members to Board of Directors
15 Jun 2006 16:11

Cerebricon Announces Updates To Product Portfolio
16 May 2006 15:12

Cerebricon Ltd. Opens Business Offices in USA and UK
19 Dec 2005 11:52

Cerebricon Ltd. Poster Sessions Society for Neuroscience
26 Sep 2005 09:28

Cerebricon Ltd. Announces Release of New Model for Schizophrenia
30 Jun 2005 15:32

Cerebricon Releases Model for Spinal Cord Injury
30 Jun 2005 15:32

Cerebricon Ltd. Appoints New Chief Executive Officer
14 Feb 2005 10:35

Cerebricon Ltd. Abstracts and Presentations for SFN 2004
19 Oct 2004 10:34